×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [3]
上海药物研究所 [1]
近代物理研究所 [1]
内容类型
期刊论文 [5]
发表日期
2021 [5]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共5条,第1-5条
帮助
限定条件
发表日期:2021
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:
Peng, Jie
;
Zou, Dan
;
Han, Lijie
;
Yin, Zuomin
;
Hu, Xiao
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/02/14
non-small cell lung cancer
support vector machine
major pathological response
liquid immune profiling
neoadjuvant treatment
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Zhang, Xiangyu
;
Zeng, Liang
;
Li, Yizhi
;
Xu, Qinqin
;
Yang, Haiyan
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2021/03/15
Anlotinib
Immunotherapy
Programmed death 1 inhibitor
Lung cancer
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
期刊论文
NANO TODAY, 2021, 卷号: 36, 页码: 12
作者:
Zhou, Fengqi
;
Gao, Jing
;
Xu, Zhiai
;
Li, Tianliang
;
Gao, Ang
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2021/06/11
Tumor microenvironment
Prodrug nanovesicles
Cancer immunotherapy
Immunogenic cell death
Adaptive immune resistance
The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12
作者:
Shen, Dijian
;
Chen, Qixun
;
Wu, Jie
;
Li, Jianqiang
;
Tao, Kaiyi
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2021/04/26
Neoadjuvant immunotherapy
esophageal squamous cell carcinoma (ESCC)
thoracic surgery
programmed death 1 (PD-1)
Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis
期刊论文
CANCER MEDICINE, 2021, 页码: 19
作者:
Geng, Yichao
;
Zhang, Qiuning
;
Feng, Shuangwu
;
Li, Chengcheng
;
Wang, Lina
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2021/12/10
combined radio-immunotherapy
meta-analysis
non-small-cell lung cancer
programmed cell death protein-1/programmed cell death ligand-1 inhibitors
radiotherapy
systematic review
©版权所有 ©2017 CSpace - Powered by
CSpace